BPC-157 should not replace conventional medical treatment for serious gastrointestinal conditions
gastric ulcers, duodenal ulcers, and mucosal erosion where direct local peptide delivery to the damaged tissue is the therapeutic goal Inflammatory bowel conditions: Crohn's disease and ulcerative colitis support, where VEGF-mediated mucosal angiogenesis and anti-inflammatory effects have been investigated Leaky gut and intestinal hyperpermeability: tight junction restoration and mucosal integrity support in patients with compromised gut barrier function Gastroparesis: pro-motility effects via vagal cholinergic pathways investigated in preclinical models of delayed gastric emptying
British Journal of Clinical Pharmacology 75 (3)
Additionally, Bacillus subtilis , a commensal microbe, can inhibit the aggregation of -synuclein in both young and aged Caenorhabditis elegans models of synucleinopathy in varied pathways (Goya et al., 2020)
European Drug Report 2017: Trends and Developments (2017)
While Tirzepatide is safe for most adults, it may not be recommended if you: Your provider will evaluate any medical conditions, medications, or allergies during your consultation
